Inhaler Monitoring Device – Documents the Date and Time the Inhaler is Used
On the September 6, 2017, the United States Food and Drug Administration (FDA) granted a company called Adherium approval for use of the SmartTouch with the Symbicort inhaler. Symbicort is approved to treat both patients with asthma and COPD. It contains a long-acting beta-agonist bronchodilator – formoterol – and an inhaled corticosteroid – budesonide.
The SmartTouch device features three buttons, which allow patients to access the audio visual-reminders and battery monitoring. The platform incorporates a Bluetooth enabled sensor and smartphone application to detect and record actual usage (date and time) of inhaled medications. The company offers different Smart inhaler sensor configurations, which are compatible with multiple medications.
The SmartTouch transmits this information to an app on the patient’s mobile or tablet device. Physicians can review the history of medication use and patterns to make suggestions to their patients. It can also be used in home monitoring programs, including hospital re-admission prevention programs.
Symbicort inhaler with SmartTouch monitoring device
Arik Anderson, the CEO of Adherium, said: “The SmartTouch for Symbicort is the most advanced Smart inhaler monitoring device to date. With each new generation, our Smart inhalers get smaller, easier to use, and incorporate more sensors that generate higher quality data, and higher levels of medication adherence.”
The recent FDA approval follows previous approval (June 2, 2014) of an earlier SmartTouch device shown below. Note how the current version of the SmartTouch is smaller than the one pictured with the albuterol inhaler.
Arik Anderson, CEO of Adherium
SmartTouch device used with albuterol metered-dose inhaler